The purpose of the current study was to validate the specificity and affinity of RP-1 in both in vitro and in vivo experiments, and to explore the diagnostic and prognostic potentials of RP-1 for GC, therefore supporting RP-1 as an ideal molecular probe for further clinical application in both diagnosis and prognosis prediction of GC. This evidence concerns the gene RP1 and gastric cancer.